Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03785860 · ClinicalTrials.gov registry record · NA
The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects
A NA study of Gut -Microbiota, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03785860: Completed NA study of Gut -Microbiota, sponsored by University of California, Davis.
NCT03785860 is a NA study of Gut -Microbiota that has completed, run by University of California, Davis. The registered enrollment target is 20 participants, below the 48-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03785860, a NA study of Gut -Microbiota, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, overall gut health, and markers of inflammation.
Primary Outcome
Gene sequencing and data analysis will be conducted to explore the change in gut microbial abundance and diversity. Specifically, the primary outcome measure will be change in the proportion of Bifidobacterium, Lactobacillus, and/or Akkermansia muciniphila.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Dietary Fiber
Study Locations (1)
California
- University of California, Davis Department of Nutrition - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2019-12-23 |
| Phase | NA |
What the finished NCT03785860 record still lists
NCT03785860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 48-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Gut -Microbiota appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03785860 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03785860 about?
NCT03785860 is a clinical study titled "The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects". The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, ove...
What is the current status of trial NCT03785860?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-05-13. Estimated completion is 2019-12-23.
What conditions does trial NCT03785860 study?
This clinical trial studies the following conditions: Gut -Microbiota.
What interventions are being tested in trial NCT03785860?
The interventions under investigation include: Placebo (OTHER), Dietary Fiber (OTHER).
Who is sponsoring clinical trial NCT03785860?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03785860 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut -Microbiota
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03785860's enrollment target sits among peer trials
20 9th of 9 higher than 1 of 9 other Gut -Microbiota trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut -Microbiota trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walnuts as an Infant Solid Food for Health
RECRUITING · NA
-
Dietary Wild Blueberries and Joint Health
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Peanuts for Cardiometabolic, Brain, and Intestinal Health
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
-
Gut Mini-Pill Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI